News

A new study sought to quantify the impacts of various testing strategies. It found rapid testing and self-isolation were the most critical factors.

Weekly, we identify which FDA recall announcements might be most clinically relevant.

The following is a quick review of the week’s top FDA approvals and authorizations.

The phase 1/2 findings show the recently regulated two-dose vaccine was associated with no serious adverse events and antibody response within 21 days.

At a time when schools and college campuses have reopened, an expert discusses adolescents' trends in spreading COVID-19 more easily, and the lack of testing available to them.

This test simultaneously detects and differentiates between SARS-CoV-2, influenza A and B.

Frontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.

JAMA Internal Medicine study focused on patients with mild disease.

A review of the week's top infectious disease news, including links established between mental health and pursuit of need medical care during COVID-19.

New study suggests a connection between widespread mental health challenges and the decline in care during COVID-19.

If phase 1/2 data is positive, the companies plan to move into phase 3 by December.

Odds of better clinical status were higher for patients with moderate COVID-19 who received a 5-day course of remdesivir than for those receiving standard care, according to the most recent randomized clinical trial of the antiviral drug.

Rinki Varindani Desai shares some of the challenges COVID-19 patients with lung injury have faced with Medicare after leaving the hospital.

The federal agency sent a checklist and priority list to all 50 states and 5 large American cities as it prepares for vaccine approval.

Dysphagia specialist Rinki Varindani Desai shares her perspective on how COVID-19 has impacted her work and patients.

A team at UCSF has created a model which estimates how many pediatric cases are going unnoticed in any US county at any time.

A trio of studies appearing in JAMA today now support steroid use to reduce mortality in patients with severe SARS-CoV-2 infections.

The test designed to detect SARS-CoV-2 will be available in Europe later this month and provides results in 15 minutes.

A pharmacokinetic and safety substudy found that the 50 mg film-coated adult dose of dolutegravir given once daily is safe and effective for children with HIV weighing 20 kg or more.

Adults appear to have a higher risk of IBD if they have been prescribed antibiotics, according to a new large study.

Heat Biologics CEO Jeff Wolf talks with Contagion about the firm's effort to develop a vaccine for the coronavirus which can potentially be administered for some seniors by taking advantage of prior immune mechanisms.

One effort to develop a SARS-CoV-2 vaccine focuses on combining antibody and T cell immunity, using a gp96 protein based technology.

The Roche test supports rapid molecular detection of acute HIV infection, with differentiation between HIV-1 and -2.

The company is recruiting up to 30000 Americans for AZD1222, its vaccine candidate, as it enters a late-stage trial.

A new analysis of excess deaths suggests the peak of the current pandemic in New York City had a death rate in the same league as the infamous 1918 influenza pandemic.

Analysis finds 2-day “lag” in case counts, potentially suggesting testing delays.

A new CDC Morbidity and Mortality Weekly Report adds information on seroprevalence of SARS-CoV-2 among health care workers in a 13-hospital multistate medical network between April and June of 2020.

A study team examined asthma prevalence in patients hospitalized for COVID-19 with population asthma prevalence and a 4-year average of asthma prevalence in influenza hospitalizations across the United States.